Continuous Glucose Monitoring in the Operating Room and Cardiac Intensive Care Unit

Perez-Guzman, Mireya C.; Duggan, Elizabeth W.; Gibanica, Seid; Cardona, Saumeth; Corujo-Rodriguez, Andrea; Faloye, Abimbola; Halkos, Michael E.; Umpiérrez, Guillermo E.; Davis, Georgia; Pasquel, Francisco J.

doi:10.2337/dc20-2386

Cited by 43 publications

(36 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this study, we also found patients in the control group experienced the largest percentage of TBR, leading to an illusion that the control group might have a higher chance of suffering hypoglycemic attacks. However, we consider this result was not clinically significant because the normal range of glucose level could extend down to 3 mmol/L (39) and interstitial glucose detected by CGM was usually lower than capillary or venous glucose (16,40). Therefore, a glucose level below the target range (4 mmol/L) but above 3 mmol/L could be regarded as normal values for patients in our control group.…”

Section: Discussionmentioning

confidence: 93%

“…Besides, CGM devices might be more suitable for these patients. It can provide the patient with more meticulous care of glucose while bringing no extra painful experiences, and it can also reduce the workload and the burden for nurses (16). Meanwhile, patients who received PD or DP might share a similar strategy during the perioperative period.…”

Section: Discussionmentioning

confidence: 99%

“…In this study, the sensor was implanted on the lateral side of the right upper arm for all participants. To avoid potential disturbance brought by electrothermal surgical devices (16), sensors were placed and activated in the postanesthesia care unit (PACU) right after the surgery. After the device had been set for over 14 days or the patient was discharged, the sensor was removed from the patient, and all data were gathered.…”

Section: Cgm System and Glucose Monitoringmentioning

confidence: 99%

“…CGM has been widely used to improve glycemic control in outpatients with diabetes mellitus (12)(13)(14). It also has been introduced for inpatients in the intensive care unit (ICU), or those receiving cardiac or neurosurgeries (15)(16)(17)(18). The characteristics of CGM above making it especially suitable for monitoring and evaluating the perioperative glycemic status after pancreatic surgery: all glucose values recorded every 15 minutes can help us to know the pattern of glycemic fluctuation after surgery, and the real-time monitoring is able to recognize potential hyper-or hypoglycemic attacks and avoid serious complications.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Evaluating perioperative glycemic status after different types of pancreatic surgeries via continuous glucose monitoring system: a pilot study

et al. 2021

View full text Add to dashboard Cite

Background: Perioperative glycemic status after pancreatic surgery has never been described. However, it's essential for optimal perioperative glucose management and understanding the pathogenesis of new-onset diabetes mellitus (NODM) after pancreatectomy. Continuous glucose monitoring (CGM) system provides us a helpful tool for closely monitoring and studying perioperative glucose change. This study tried to describe and compare perioperative glucose level and glycemic variability between different types of pancreatic surgeries via CGM device.Methods: This study was designed as a prospective observational study. Eighteen patients were enrolled and were grouped by different types of surgery received: control group (CTRL), pancreaticoduodenectomy (PD), distal pancreatectomy (DP), and total pancreatectomy (TP). CGM devices were implanted and initiated right after the surgery. Mean glucose value (MGV), coefficient of variation (CV), mean of daily difference (MODD), continuous overall net glycemic action (CONGA), and time above range (TAR)/time below range (TBR) was compared between groups to assess glucose level and glycemic variability.Results: TP showed the highest MGV and CV among all groups (P<0.001), while CTRL showed the lowest (P<0.001). PD and DP had similar MGV and CV lower than TP but higher than CTRL (P<0.001).TP had the highest MODD and CONGA, CTRL had the lowest, but no significant differences were found between groups. TP had the highest TAR (24.29%) and the lowest TBR (1.28%), while the control group showed the opposite. The differences in TAR/TBR between groups were all significant (P<0.05).Conclusions: TP had the highest mean glucose level and the greatest glycemic variability. PD and DP had similar results: a higher mean glucose level than control but lower than TP. For glycemic variability, PD and DP seemed to have a near-normal result resembling the control group. CGM is useful for glucose monitoring in the perioperative management of pancreatic surgery.

show abstract

Section: Discussionmentioning

confidence: 93%

Section: Discussionmentioning

confidence: 99%

Section: Cgm System and Glucose Monitoringmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Evaluating perioperative glycemic status after different types of pancreatic surgeries via continuous glucose monitoring system: a pilot study

et al. 2021

View full text Add to dashboard Cite

show abstract

“…For the accuracy studies that utilized the Dexcom G6 system (Dexcom, Inc., San Diego, CA, USA), the overall mean absolute relative difference (MARD) ranged between 9.4–12.9% and the median absolute relative difference (ARD) ranged between 9.9 and 10.5% [ 24 ▪▪ , 25 – 27 ]. A large multicenter pooled accuracy analysis of CGM data from 218 medicine and surgery patients ( n = 4067 matched glucose pairs) with diabetes revealed a MARD of 12.8% and median ARD of 10.1% [ 24 ▪▪ ].…”

Section: Methodsmentioning

confidence: 99%

Continuous glucose monitoring in the hospital: an update in the era of COVID-19

Gothong

Singh

Satyarengga

et al. 2021

Current Opinion in Endocrinology, Diabetes &Amp; Obesity

View full text Add to dashboard Cite

Purpose of review Continuous glucose monitoring (CGM) systems are Food and Drug Administration approved devices for the ambulatory setting; however, they remain investigational systems for inpatient use. This review summarizes the most recent and relevant literature on the use of continuous glucose monitoring in the hospital setting. Recent findings CGM provides real-time glucose data that enable healthcare professionals to make proactive and timelier clinical decisions with regards to diabetes management. CGM devices appear to be safe and accurate systems for glucose monitoring in the hospital setting. Real-time CGM systems and glucose telemetry can decrease hypoglycemia and reduce hyperglycemia in hospitalized patients with diabetes. Remote glucose monitoring decreases the need of frequent Point-of-care checks and personal protective equipment use while also mitigating staff exposure risk which is timely in the advent of the COVID-19 pandemic. Although most nursing staff have limited exposure and training on CGM technology, early studies show that CGM use in the hospital is well received by nurses. Summary Given the evidence in the current literature regarding CGM use in the hospital, CGM devices may be incorporated in the inpatient setting.

show abstract